Frequency of Translocation t(11;22)(q24;q12) Using Fluorescence In Situ Hybridization (FISH) in Histologically and Immunohistochemically Diagnosed Cases of Ewing’s Sarcoma
Open Access
- 20 August 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (8)
Abstract
Ewing sarcoma (ES) family of tumors is one of the most common groups of malignancies arising in children, adolescents, and young adults. Although characteristic histology with immunohistochemical expression of CD99 and FLI1 after exclusion of other small round blue cell tumors is considered diagnostic of ES, frequency of typical ES translocation, i.e., t(11;22)(q24;q12) is not known in our population. Therefore, in this study, we aimed to evaluate the frequency of this translocation in histologically and immunohistochemically diagnosed cases of ES along with its association with other pathological parameters. A total of 43 morphologically and immunohistochemically diagnosed cases of ES were included in the study. Fluorescence in situ hybridization (FISH) was performed on representative paraffin blocks to identify t(11;22)(q24;q12) translocation. Association with various clinicopathological characteristics was determined. Mean age of the patients was 18.23±9.57 years. Bone was the most commonly involved site (22; 51.2%) followed by soft tissue (17; 39.5%) and parenchymal organs (4; 9.3%). A total of 88.4% of cases were found to be FISH-positive for t(11;22)(q24;q12). No significant association of translocation positive cases was noted with tumor size or disease-free survival. Similarly, no significant association of tumor size with disease-free survival was found. A significant proportion of cases of histologically diagnosed cases of ES exhibited characteristic t(11;22)(q24;q12). This signifies that histology along with immunohistochemistry is reliable for the diagnosis of this tumor; however, in difficult cases, FISH can be performed to detect characteristic translocation. Moreover, we did not find tumor size to be a significant prognostic indicator of survival in ES.Keywords
This publication has 13 references indexed in Scilit:
- Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell SarcomasJournal of Clinical Oncology, 2018
- Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review2016
- [Diagnostic challenges of Ewing sarcoma-like small round blue cell tumors: an update].2015
- Molecular investigation of Ewing sarcoma: about detecting translocationsEMBO Molecular Medicine, 2012
- Molecular Diagnosis in Ewing Family TumorsThe Journal of Molecular Diagnostics, 2011
- Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumorsLaboratory Investigation, 2006
- A practical approach to the clinical diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissueJournal of Clinical Pathology, 2005
- Variability in Gene Expression Patterns of Ewing Tumor Cell Lines Differing in EWS-FLI1 Fusion TypeLaboratory Investigation, 2000
- Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?Journal of Clinical Oncology, 1996
- Diffuse Endothelioma of BoneCA: A Cancer Journal for Clinicians, 1972